The ring-infected erythrocyte surface antigen (RESA) of Plasmodium falciparum stabilizes spectrin tetramers and suppresses further invasion.

Abstract:

:The malaria parasite Plasmodium falciparum releases the ring-infected erythrocyte surface antigen (RESA) inside the red cell on entry. The protein migrates to the host cell membrane, where it binds to spectrin, but neither the nature of the interaction nor its functional consequences have previously been defined. Here, we identify the binding motifs involved in the interaction and describe a possible function. We have found that spectrin binds to a 108-amino acid fragment (residues 663-770) of RESA, and that this RESA fragment binds to repeat 16 of the beta-chain, close to the labile dimer-dimer self-association site. We further show that the RESA fragment stabilizes the spectrin tetramer against dissociation into its constituent dimers, both in situ and in solution. This is accompanied by enhanced resistance of the cell to both mechanical and thermal degradation. Resealed erythrocytes containing RESA(663-770) display resistance to invasion by merozoites of P falciparum. We infer that the evolutionary advantage of RESA to the parasite lies in its ability to prevent invasion of cells that are already host to a developing parasite, as well as possibly to guard the cell against thermal damage at the elevated body temperatures prevailing in febrile crises.

journal_name

Blood

journal_title

Blood

authors

Pei X,Guo X,Coppel R,Bhattacharjee S,Haldar K,Gratzer W,Mohandas N,An X

doi

10.1182/blood-2007-02-076919

subject

Has Abstract

pub_date

2007-08-01 00:00:00

pages

1036-42

issue

3

eissn

0006-4971

issn

1528-0020

pii

blood-2007-02-076919

journal_volume

110

pub_type

杂志文章

相关文献

BLOOD文献大全
  • A new pet for myeloma.

    abstract::In this issue of Blood, Bartel and colleagues report the independent predictive value of the PET/CT and of the FDG suppression before transplantation in newly diagnosed myeloma patients who were treated using the TT3 regimen. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2009-06-224196

    authors: Dimopoulos MA,Moulopoulos LA,Terpos E

    更新日期:2009-09-03 00:00:00

  • Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.

    abstract::The FOXP1 forkhead transcription factor is targeted by recurrent chromosome translocations in several subtypes of B-cell non-Hodgkin lymphomas, where high-level FOXP1 protein expression has been linked to a poor prognosis. Western blotting studies of diffuse large B-cell lymphoma (DLBCL) cell lines unexpectedly identi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-115113

    authors: Brown PJ,Ashe SL,Leich E,Burek C,Barrans S,Fenton JA,Jack AS,Pulford K,Rosenwald A,Banham AH

    更新日期:2008-03-01 00:00:00

  • Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.

    abstract::We here investigate the occurrence of fluoride intake-associated alterations in patients with hematologic disease on triazol antifungal medication. Clinical, laboratory, and radiology data of overall 43 patients with hematologic malignancies taking voriconazole (n = 20), posaconazole (n = 8), and itraconazole (n = 4),...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-403030

    authors: Gerber B,Guggenberger R,Fasler D,Nair G,Manz MG,Stussi G,Schanz U

    更新日期:2012-09-20 00:00:00

  • Alpha-Chain cross-linking in fibrin(ogen) Marburg.

    abstract::The fibrinogen structural variant, Marburg (A alpha 1-460B beta gamma)2, is comprised of normal B beta and gamma chains but contains severely truncated A alpha chains that are missing approximately one half of their factor XIIIa cross-linking domain. Immunochemical studies of fibrin(ogen) Marburg were conducted to cha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sobel JH,Trakht I,Wu HQ,Rudchenko S,Egbring R

    更新日期:1995-08-01 00:00:00

  • CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique.

    abstract::CD4(+), CD56(+) DC2 malignancies constitute a novel disease entity, which has recently been shown to arise from a transformed lymphoid-related plasmacytoid dendritic cell (DC2). Diagnosis is primarily based on a particular immunophenotype with tumor cells expressing CD4 and CD56 antigens in the absence of common lymph...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood.v99.11.4154

    authors: Leroux D,Mugneret F,Callanan M,Radford-Weiss I,Dastugue N,Feuillard J,Le Mée F,Plessis G,Talmant P,Gachard N,Uettwiller F,Pages MP,Mozziconacci MJ,Eclache V,Sibille C,Avet-Loiseau H,Lafage-Pochitaloff M

    更新日期:2002-06-01 00:00:00

  • Recipient T lymphocytes modulate the severity of antibody-mediated transfusion-related acute lung injury.

    abstract::Transfusion-related acute lung injury (TRALI) is a serious complication of transfusion and has been ranked as one of the leading causes of transfusion-related fatalities. Nonetheless, many details of the immunopathogenesis of TRALI, particularly with respect to recipient factors are unknown. We used a murine model of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-284570

    authors: Fung YL,Kim M,Tabuchi A,Aslam R,Speck ER,Chow L,Kuebler WM,Freedman J,Semple JW

    更新日期:2010-10-21 00:00:00

  • p15ink4B and p16ink4 gene inactivation in acute lymphocytic leukemia.

    abstract::Malignant cells from 52 children with acute lymphocytic leukemia (ALL) were investigated for inactivation of the p15ink4B and p16ink4 genes and other genetic alterations on chromosome 9p21. Homozygous deletions of the p15ink4B and/or the p16ink4 genes were detected in 16 cases and a further 9 cases showed evidence of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rasool O,Heyman M,Brandter LB,Liu Y,Grandér D,Söderhäll S,Einhorn S

    更新日期:1995-06-15 00:00:00

  • Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells.

    abstract::The plasminogen activator inhibitor PAI-1 is markedly elevated in vivo and in vitro upon exposure to the inflammatory mediators tumor necrosis factor alpha (TNF alpha), interleukin-1 (IL-1), and bacterial lipopolysaccharide. Here we report that the isoflavone compound genistein prevents the increase in synthesis of PA...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Hinsbergh VW,Vermeer M,Koolwijk P,Grimbergen J,Kooistra T

    更新日期:1994-11-01 00:00:00

  • Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production.

    abstract::Mammalian TOR (mTOR) regulates cell growth, proliferation, and migration. Because mTOR knock-outs are embryonic lethal, we generated a viable hypomorphic mouse by neo-insertion that partially disrupts mTOR transcription and creates a potential physiologic model of mTORC1/TORC2 inhibition. Homozygous knock-in mice exhi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-287821

    authors: Zhang S,Readinger JA,DuBois W,Janka-Junttila M,Robinson R,Pruitt M,Bliskovsky V,Wu JZ,Sakakibara K,Patel J,Parent CA,Tessarollo L,Schwartzberg PL,Mock BA

    更新日期:2011-01-27 00:00:00

  • Ph1-positive, bcr-negative acute leukemias: clustering of breakpoints on chromosome 22 in the 3' end of the BCR gene first intron.

    abstract::About 50% of the Philadelphia-positive acute leukemias undergo molecular rearrangements outside the now classical bcr sequence (or M-BCR-1) rearranged in chronic myeloid leukemia (CML). Most of the breakpoints on chromosome 22 have been shown to be clustered in a 10.8-kb region of the first intron of the BCR gene (cal...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chen SJ,Chen Z,Hillion J,Grausz D,Loiseau P,Flandrin G,Berger R

    更新日期:1989-04-01 00:00:00

  • BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase.

    abstract::BCR-ABL antisense oligodeoxynucleotides (ODN) have provided evidence of antileukemia effect when tested in vitro against Philadelphia-positive (Ph-pos) cells and in vivo when injected into leukemic mice. On the basis of the results obtained in vitro at diagnosis, eight patients with chronic myelogenous leukemia (CML) ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: de Fabritiis P,Petti MC,Montefusco E,De Propris MS,Sala R,Bellucci R,Mancini M,Lisci A,Bonetto F,Geiser T,Calabretta B,Mandelli F

    更新日期:1998-05-01 00:00:00

  • A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma.

    abstract::Mitochondrial DNA (mtDNA) copy number is increased in patients with chronic lymphocytic leukemia (CLL), in Burkitt lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines, and in T cells activated via the T-cell receptor. We hypothesized that having a higher mtDNA copy number in peripheral white blood ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-05-157974

    authors: Lan Q,Lim U,Liu CS,Weinstein SJ,Chanock S,Bonner MR,Virtamo J,Albanes D,Rothman N

    更新日期:2008-11-15 00:00:00

  • Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin.

    abstract::Liver X receptors (LXRs) are nuclear receptors regulating lipid and cholesterol metabolism. Recent data revealed a cross talk between LXR and Toll-like receptor signaling in macrophages, indicating a role in immunity. Here, we show that LXRalpha is expressed in human myeloid dendritic cells (DCs) and induced during di...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-08-043422

    authors: Geyeregger R,Zeyda M,Bauer W,Kriehuber E,Säemann MD,Zlabinger GJ,Maurer D,Stulnig TM

    更新日期:2007-05-15 00:00:00

  • Mouse and human HSPC immobilization in liquid culture by CD43- or CD44-antibody coating.

    abstract::Keeping track of individual cell identifications is imperative to the study of dynamic single-cell behavior over time. Highly motile hematopoietic stem and progenitor cells (HSPCs) migrate quickly and do not adhere, and thus must be imaged very frequently to keep cell identifications. Even worse, they are also flushed...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-07-794131

    authors: Loeffler D,Wang W,Hopf A,Hilsenbeck O,Bourgine PE,Rudolf F,Martin I,Schroeder T

    更新日期:2018-03-29 00:00:00

  • Specialized regulatory T cells control venous blood clot resolution through SPARC.

    abstract::The cells and mechanisms involved in blood clot resorption are only partially known. We show that regulatory T (Treg) cells accumulate in venous blood clots and regulate thrombolysis by controlling the recruitment, differentiation and matrix metalloproteinase (MMP) activity of monocytes. We describe a clot Treg popula...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005407

    authors: Shahneh F,Alexandra G,Klein M,Frauhammer F,Bopp T,Schäfer K,Raker V,Becker C

    更新日期:2020-09-15 00:00:00

  • A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.

    abstract::This study investigated the immunogenicity of Wilms tumor gene product 1 (WT1)-peptide vaccination in WT1-expressing acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients without curative treatment option. Vaccination consisted of granulocyte-macrophage colony-stimulating factor subcutaneously days ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-202598

    authors: Keilholz U,Letsch A,Busse A,Asemissen AM,Bauer S,Blau IW,Hofmann WK,Uharek L,Thiel E,Scheibenbogen C

    更新日期:2009-06-25 00:00:00

  • Intravascular hemolysis and renal insufficiency after bone marrow transplantation.

    abstract::Renal disease has not been considered a major late complication of bone marrow transplantation. Of 31 evaluable pediatric patients undergoing allogeneic or autologous bone marrow transplantation for neuroblastoma or acute lymphoblastic leukemia, 14 developed a hemolytic anemia, microscopic hematuria, and renal insuffi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Guinan EC,Tarbell NJ,Niemeyer CM,Sallan SE,Weinstein HJ

    更新日期:1988-08-01 00:00:00

  • CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma.

    abstract::Primary effusion lymphoma (PEL) is an aggressive subtype of non-Hodgkin lymphoma characterized by short survival with current therapies, emphasizing the urgent need to develop new therapeutic approaches. Brentuximab vedotin (SGN-35) is an anti-CD30 monoclonal antibody (cAC10) conjugated by a protease-cleavable linker ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-01-481713

    authors: Bhatt S,Ashlock BM,Natkunam Y,Sujoy V,Chapman JR,Ramos JC,Mesri EA,Lossos IS

    更新日期:2013-08-15 00:00:00

  • Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity.

    abstract::Some B-cell neoplasms, including hairy cell leukemia (HCL), lack expression of the adhesion molecule leukocyte function antigen-1 (LFA-1/CD11a). Additionally, HCL cells express relatively low amounts of intercellular adhesion molecule-1 (ICAM-1/CD54) and may therefore be an inappropriate target for recognition by T ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jansen JH,van der Harst D,Wientjens GJ,Kooy-Winkelaar YM,Brand A,Willemze R,Kluin-Nelemans HC

    更新日期:1992-07-15 00:00:00

  • Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

    abstract::We have recently shown that proteasome inhibitor PS-341 induces apoptosis in drug-resistant multiple myeloma (MM) cells, inhibits binding of MM cells in the bone marrow microenvironment, and inhibits cytokines mediating MM cell growth, survival, drug resistance, and migration in vitro. PS-341 also inhibits human MM ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-08-2543

    authors: Hideshima T,Mitsiades C,Akiyama M,Hayashi T,Chauhan D,Richardson P,Schlossman R,Podar K,Munshi NC,Mitsiades N,Anderson KC

    更新日期:2003-02-15 00:00:00

  • Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl.

    abstract::Bcr-Abl tyrosine kinase activity initiates a number of intracellular signaling cascades that result in leukemogenesis. Imatinib mesylate, a specific Bcr-Abl tyrosine kinase inhibitor, has been highly successful in the treatment of chronic myelogenous leukemia (CML). However, the emergence of imatinib resistance and th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-10-3864

    authors: Gu JJ,Santiago L,Mitchell BS

    更新日期:2005-04-15 00:00:00

  • Phenotype analysis of hematopoietic CD34+ cell populations derived from human umbilical cord blood using flow cytometry and cDNA-polymerase chain reaction.

    abstract::A strategy to phenotype rare populations of hematopoietic cells expressing the cell-surface marker CD34 was studied. The antigenic phenotype of umbilical core blood (CB) CD34+ cells was investigated using flow cytometry and compared with the mRNA-phenotype determined by cDNA-polymerase chain reaction (cDNA-PCR) analys...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Thoma SJ,Lamping CP,Ziegler BL

    更新日期:1994-04-15 00:00:00

  • Characterization and pharmacokinetic parameters of recombinant soluble interleukin-4 receptor.

    abstract::The interleukin-4 receptor (IL-4R) is expressed as a 140-Kd membrane glycoprotein that binds IL-4 with high affinity. Recently, cDNA clones for the murine IL-4R have been isolated. One clone encodes an integral membrane protein, while another encodes a protein in which translation is terminated before the transmembran...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jacobs CA,Lynch DH,Roux ER,Miller R,Davis B,Widmer MB,Wignall J,VandenBos T,Park LS,Beckmann MP

    更新日期:1991-06-01 00:00:00

  • Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial.

    abstract::This prospective multicenter study examined whether simultaneous administration of granulocyte colony-stimulating factor (G-CSF; Filgrastim) and induction chemotherapy for adult acute lymphoblastic leukemia (ALL) could prevent treatment-related neutropenia, infections, and resulting treatment delays. Seventy-six patie...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Ottmann OG,Hoelzer D,Gracien E,Ganser A,Kelly K,Reutzel R,Lipp T,Busch FW,Schwonzen M,Heil G

    更新日期:1995-07-15 00:00:00

  • Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase.

    abstract::Despite the importance of phosphoinositide 3-kinase (PI3K) in B-cell development, its activation mechanism still remains elusive. In this study, we show that deletion of both BCAP and CD19 leads to an almost complete block of BCR-mediated Akt activation and to severe defects in generation of immature and mature B cell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-08-109769

    authors: Aiba Y,Kameyama M,Yamazaki T,Tedder TF,Kurosaki T

    更新日期:2008-02-01 00:00:00

  • Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma.

    abstract::The majority of diffuse large B-cell lymphoma (DLBCL) tumors contain mutations in histone-modifying enzymes (HMEs), indicating a potential therapeutic benefit of histone deacetylase inhibitors (HDIs), and preclinical data suggest that HDIs augment the effect of rituximab. In this randomized phase 2 study, we evaluated...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2016-02-699520

    authors: Assouline SE,Nielsen TH,Yu S,Alcaide M,Chong L,MacDonald D,Tosikyan A,Kukreti V,Kezouh A,Petrogiannis-Haliotis T,Albuquerque M,Fornika D,Alamouti S,Froment R,Greenwood CM,Oros KK,Camglioglu E,Sharma A,Christodoulopoul

    更新日期:2016-07-14 00:00:00

  • Exogenous heat shock protein 70 binds macrophage lipid raft microdomain and stimulates phagocytosis, processing, and MHC-II presentation of antigens.

    abstract::The extracellular presence of endotoxin-free heat shock protein 70 (HSP70) enhances the rate and capacity of macrophage-mediated phagocytosis at 6 times the basal rate. It is protein-specific, dose- and time-dependent and involves the internalization of inert microspheres, Gram-positive and -negative bacteria and fung...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-06-2559

    authors: Wang R,Kovalchin JT,Muhlenkamp P,Chandawarkar RY

    更新日期:2006-02-15 00:00:00

  • Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors.

    abstract::To assess a possible role in tumor progression, the occurrence and type of K- and N-RAS mutations were determined in purified tumor cells, including samples from patients with premalignant monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), and extramedullary plasma cell (PC) tumors (ExPC...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-0833

    authors: Rasmussen T,Kuehl M,Lodahl M,Johnsen HE,Dahl IM

    更新日期:2005-01-01 00:00:00

  • Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated.

    abstract::We studied the relationship between the production of the 23-Kd interleukin-1 receptor antagonist (IL-1ra) and IL-1 beta in cultures of human peripheral blood mononuclear cells (PBMC) using a specific radioimmunoassay for IL-1ra that had a sensitivity of 166 +/- 11 pg/mL. PBMC cultured without human serum made little ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Poutsiaka DD,Clark BD,Vannier E,Dinarello CA

    更新日期:1991-09-01 00:00:00

  • The secretory pathway of bovine platelets.

    abstract::Human platelets contain tortuous channels in their cytoplasm, the surface-connected or open canalicular system (OCS), that communicate directly with the surrounding medium through openings on the surface membrane. Some workers have suggested that the OCS serves as the egress route for products secreted during the rele...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: White JG

    更新日期:1987-03-01 00:00:00